Mirati Therapeutics

AACR: 2 years in, Amgen fortifies Lumakras lung cancer data fortress for upcoming Mirati, Novartis KRAS battle
Fierce Pharma
Sun, 04/10/22 - 07:46 pm
AACR
Amgen
Lumakras
Mirati Therapeutics
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
drug launches
Eli Lilly
tirzepatide
Alnylam
vutrisiran
Roche
Vabysmo
JNJ
Carvykti
Mirati Therapeutics
adagrasib
Bristol Myers Squibb
mavacamten
deucravacitinib
Amgen hold-up gives Mirati a vital lifeline
EP Vantage
Thu, 02/10/22 - 10:12 am
Amgen
Mirati Therapeutics
Lumakras
lung cancer
clinical trials
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Mirati Therapeutics
Amgen
KRAS
clinical trials
Merck
Keytruda
Mirati, Sanofi join forces in lung cancer with a KRAS-SHP2 combo approach
Fierce Biotech
Fri, 10/8/21 - 10:34 am
Sanofi
Mirati Therapeutics
adagrasib
non-small cell lung cancer
Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT
Fierce Pharma
Wed, 10/6/21 - 11:26 pm
Merck
M&A
Biogen
Mirati Therapeutics
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug
Fierce Biotech
Mon, 09/20/21 - 12:00 am
ESMO
Mirati Therapeutics
Amgen
colorectal cancer
ESMO 2021 – Mirati bids to be belle of the ball
EP Vantage
Tue, 09/14/21 - 10:41 am
ESMO
Mirati Therapeutics
Faron Pharmaceuticals
Amgen
Spectrum Pharmaceuticals
Mirati fiddles as its share price burns
EP Vantage
Thu, 08/12/21 - 11:07 am
Mirati Therapeutics
Amgen
Lumakras
adagrasib
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial
Fierce Biotech
Thu, 03/11/21 - 10:47 am
Eli Lilly
KRAS
Amgen
Mirati Therapeutics
LY3499446
solid tumors
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Sun, 10/25/20 - 11:30 pm
Mirati Therapeutics
Amgen
adagrasib
lung cancer
Mirati's Sitravatinib Shows Promising Phase II Results in Urothelial Cancer Patients
BioSpace
Mon, 09/21/20 - 11:40 pm
Mirati Therapeutics
sitravantinib
ESMO
urothelial cancer
Mirati's sitravatinib in combination with nivolumab shows 37% response rate in urothelial cancer
Seeking Alpha
Fri, 09/18/20 - 10:45 am
ESMO
Mirati Therapeutics
clinical trials
sitravantinib
Opdivo
urothelial cancer
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Thu, 12/5/19 - 10:15 am
Biotech Beach
San Diego
California
Amgen
Neurocrine
Acadia Pharmaceuticals
Retrophin
Tocagen
Mirati Therapeutics
AnaptysBio
Triple meeting – Mirati avoids the worst-case scenario
EP Vantage
Tue, 10/29/19 - 10:34 am
Mirati Therapeutics
MRTX849
lung cancer
colorectal cancer
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Mirati sets date for closely watched clinical KRAS readout
Fierce Biotech
Fri, 10/18/19 - 10:12 am
Mirati Therapeutics
KRAS
MRTX849
Amgen
cancer

Pages